Risk factor
Strong & resilient to price shocks
Profitability factor
Undervalued vs peers
About
Zhejiang Medicine Co., Ltd. is a Chinese enterprise specializing in the manufacturing and distribution of both nutritional supplements and pharmaceutical goods. Its life nutrition portfolio encompasses a wide array of offerings, such as synthetic and natural vitamin E, vitamin A, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, and lycopene, alongside various other vitamin compounds. Beyond nutrition, the company is a significant supplier in the pharmaceutical sector. This includes the production of active pharmaceutical ingredients and raw materials like specialized antibiotics for drug-resistant strains, anti-malarial compounds, and quinolone derivatives. Furthermore, it develops and markets finished pharmaceutical products, notably sugar-based medications and hormonal preparations. Established in 1997, Zhejiang Medicine Co., Ltd. maintains its headquarters in Shaoxing, China.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reasonably priced on P
Target Price
The average target price of 600216.SS is 16.9 and suggests 34.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to